Detalhe da pesquisa
1.
Phase Ib study of sabatolimab (MBG453), a novel immunotherapy targeting TIM-3 antibody, in combination with decitabine or azacitidine in high- or very high-risk myelodysplastic syndromes.
Am J Hematol
; 99(2): E32-E36, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994196
2.
Novel immune directed therapies in myelodysplastic syndromes and acute myeloid leukemia.
Curr Opin Hematol
; 30(2): 38-44, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36728945
3.
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromes.
Am J Hematol
; 98(2): 272-281, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309981
4.
Chemotherapy Resistance in B-ALL with Cryptic NUP214-ABL1 Is Amenable to Kinase Inhibition and Immunotherapy.
Oncologist
; 27(2): 82-86, 2022 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641210
5.
Correlation of p53 immunohistochemistry with TP53 mutational status and overall survival in newly diagnosed acute myeloid leukaemia.
Histopathology
; 81(4): 496-510, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869818
6.
Outcome of relapsed or refractory acute B-lymphoblastic leukemia patients and BCR-ABL-positive blast cell crisis of B-lymphoid lineage with extramedullary disease receiving inotuzumab ozogamicin.
Haematologica
; 107(9): 2064-2071, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35142153
7.
Characteristics and outcome of patients with core-binding factor acute myeloid leukemia and FLT3-ITD: results from an international collaborative study.
Haematologica
; 107(4): 836-843, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34348451
8.
NCCN Guidelines® Insights: Myelodysplastic Syndromes, Version 3.2022.
J Natl Compr Canc Netw
; 20(2): 106-117, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130502
9.
Palliative care and coping in patients with acute myeloid leukemia: Mediation analysis of data from a randomized clinical trial.
Cancer
; 127(24): 4702-4710, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34460937
10.
Posttraumatic stress disorder symptoms in patients with acute myeloid leukemia.
Cancer
; 127(14): 2500-2506, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33764526
11.
Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study.
Br J Haematol
; 192(5): 832-842, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33529373
12.
Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark.
Blood
; 134(8): 678-687, 2019 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31243042
13.
Low participation rates and disparities in participation in interventional clinical trials for myelodysplastic syndromes.
Cancer
; 126(21): 4735-4743, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32767690
14.
A phase 1 study of the antibody-drug conjugate brentuximab vedotin with re-induction chemotherapy in patients with CD30-expressing relapsed/refractory acute myeloid leukemia.
Cancer
; 126(6): 1264-1273, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31860140
15.
High NPM1-mutant allele burden at diagnosis predicts unfavorable outcomes in de novo AML.
Blood
; 131(25): 2816-2825, 2018 06 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-29724895
16.
Ipilimumab plus decitabine for patients with MDS or AML in posttransplant or transplant-naïve settings.
Blood
; 141(15): 1884-1888, 2023 04 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332187
17.
Allogeneic hematopoietic cell transplantation improves outcome of adults with t(6;9) acute myeloid leukemia: results from an international collaborative study.
Haematologica
; 105(1): 161-169, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31004014
18.
Outcomes for older adults with acute myeloid leukemia after an intensive care unit admission.
Cancer
; 125(21): 3845-3852, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31299106
19.
Isocitrate dehydrogenase 1 and 2 mutations, 2-hydroxyglutarate levels, and response to standard chemotherapy for patients with newly diagnosed acute myeloid leukemia.
Cancer
; 125(4): 541-549, 2019 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30422308
20.
Case 26-2021: A 49-Year-Old Man with Relapsed Acute Myeloid Leukemia.
N Engl J Med
; 385(9): 834-843, 2021 Aug 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34437787